Highlights
KLSE: DPHARMA (7148)       DUOPHARMA BIOTECH BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
3.80   -0.21 (5.24%)  3.80 - 4.08  8,367,300
Analyze this stock with MQ Trader system

Recent Prices

Date Open Range Close Change Volume
23/10/2020 4.01 3.80 - 4.08 3.80 -0.21 (5.24%) 8,367,300
22/10/2020 4.02 3.89 - 4.05 4.01 +0.02 (0.50%) 7,303,500
21/10/2020 3.95 3.80 - 4.08 3.99 +0.10 (2.57%) 17,183,400
20/10/2020 4.06 3.88 - 4.12 3.89 -0.17 (4.19%) 11,420,500
19/10/2020 4.00 3.96 - 4.20 4.06 +0.12 (3.05%) 21,529,900
16/10/2020 3.77 3.72 - 3.95 3.94 +0.18 (4.79%) 26,025,800
15/10/2020 3.70 3.59 - 3.76 3.76 +0.09 (2.45%) 17,374,600
14/10/2020 3.63 3.61 - 3.74 3.67 +0.07 (1.94%) 12,039,500
13/10/2020 3.60 3.53 - 3.68 3.60 -0.02 (0.55%) 9,732,900
12/10/2020 3.50 3.50 - 3.75 3.62 +0.17 (4.93%) 36,587,700
09/10/2020 3.45 3.38 - 3.52 3.45 +0.01 (0.29%) 5,318,100
08/10/2020 3.47 3.40 - 3.69 3.44 +0.01 (0.29%) 24,643,800
07/10/2020 3.39 3.36 - 3.46 3.43 +0.09 (2.69%) 4,215,300
06/10/2020 3.49 3.29 - 3.51 3.34 -0.13 (3.75%) 6,735,100
05/10/2020 3.35 3.30 - 3.50 3.47 +0.14 (4.20%) 9,323,000
02/10/2020 3.46 3.28 - 3.48 3.33 -0.15 (4.31%) 14,645,100
01/10/2020 3.18 3.16 - 3.48 3.48 +0.32 (10.13%) 16,296,500
30/09/2020 3.15 3.11 - 3.17 3.16 +0.01 (0.32%) 2,505,900
29/09/2020 3.17 3.12 - 3.21 3.15 -0.02 (0.63%) 2,479,400
28/09/2020 3.15 3.10 - 3.22 3.17 +0.03 (0.96%) 4,777,900
Trade this stock for as low as 0.05% brokerage. Find out more.

  8 people like this.
 
henry888 i don't trust any news from aljazeera. com. regarding China as she is pro US. Again, the president of Brazil's remarks in my opinion may be political in nature and also it is an internal affairs of the country in view of their financial constraints and the safety whether to use the vaccine. Is nothing to do with China vaccine.
22/10/2020 7:17 AM
Chrizleon19 The bull won’t be running yet. Trade accordingly to own discretion .
22/10/2020 7:25 AM
Keyman188 AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies

(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)

~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.

~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.


AstraZeneca shares turned negative Wednesday after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.

Shares of AstraZeneca, a front-runner in the Covid-19 vaccine race, gave up a slight gain after the news broke. Shares were down by about 1% in early afternoon trading.

A spokesperson from AstraZeneca declined to comment on the volunteer, citing “medical confidentiality and clinical trial regulations.”

The spokesperson added that ”[a]ll significant medical events are carefully assessed by trial investigators” and ”[t]hese assessments have not led to any concerns about continuation of the ongoing study.”

In a statement, a spokesperson from the University of Oxford, which is developing the vaccine with AstraZeneca, said “there have been no concerns about safety of the clinical trial” after an assessment of the case in Brazil.

“The independent review in addition to the Brazilian regulator have recommended that the trial should continue,” Oxford spokesperson Alexander Buxton said.

Oxford provided no further details on the volunteer’s death, and it’s unclear if the volunteer received the vaccine. Brazil currently has the second deadliest outbreak in the world, behind the United States, with at least 115,914 deaths, according to data compiled by Johns Hopkins University.

A source familiar with the situation told Reuters that the trial would have been suspended if the volunteer had been a part of the group getting the shot.

The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States. That means the company is unable to administer second doses of its two-dose vaccine regimen to U.S. participants.

The company announced on Sept. 8 that its trial had been put on hold due to an unexplained illness in a patient in the United Kingdom. The patient is believed to have developed inflammation of the spinal cord, known as transverse myelitis. The trial has since resumed in the U.K. and other countries.

The U.S. is expected to resume the trial as early as this week after the FDA completed its review, Reuters reported Tuesday, citing four anonymous sources.

AstraZeneca is one of four drugmakers backed by the U.S. in late-stage testing for a potential vaccine. AstraZeneca’s vaccine, called AZD1222, uses genetic material from the coronavirus with a modified adenovirus.

In July, the company published data that showed its vaccine produced a promising immune response in an early-stage trial and appeared to be well tolerated.

The vaccine produced no serious adverse events in volunteers, according to the researchers at the time. Fatigue and headache were the most commonly reported side effects, they said. Other common side effects included pain at the injection site, muscle ache, chills and a fever.


##https://www.cnbc.com/2020/10/21/astrazeneca-shares-slide-after-brazilian-health-authority-says-volunteer-in-covid-vaccine-study-dies.html
22/10/2020 8:26 AM
Plantermen China vaccine strongly tipped to be Malaysia choice. Indonesia already pre book with China state owned lab
22/10/2020 8:28 AM
Keyman188 R.I.P....to heard that...

AstraZeneca's vaccine still not yet reach the safety consumption level...




Posted by Keyman188 > Oct 22, 2020 8:26 AM | Report Abuse X

AstraZeneca shares turn negative after Brazilian health authority says volunteer in Covid vaccine study dies

(PUBLISHED WED, OCT 21 20201:15 PM EDTUPDATED 35 MIN AGO)

~ AstraZeneca shares turned negative after a Brazilian health authority, Anvisa, said a volunteer in its coronavirus vaccine study died.

~ The Federal University of Sao Paulo, which is helping coordinate late-stage trials in Brazil, separately said that the volunteer was Brazilian, according to Reuters.

~ The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States.
22/10/2020 8:44 AM
yongyong88 big funds and insiders are buying. Swim with the big boys...
22/10/2020 8:50 AM
face All Vaccines related counter limit down...??
All Vaccines related counter limit down...??
https://edition.cnn.com/2020/10/21/health/covid-19-vaccine-trial-brazil-astrazeneca-death-bn/index.html
22/10/2020 8:51 AM
yongyong88 hope all vaccine stocks can limit down so can collect more. and ...more.let's pray n wait
22/10/2020 8:54 AM
yongyong88 waiting for limit down...another 5 minutes to opening....waiting to BUY MORE...
22/10/2020 8:55 AM
stocktrade101 all vaccine anf glove stocks up la,

https://www.globaltimes.cn/content/1204263.shtml
22/10/2020 9:12 AM
Mynameisntimportant May i know why you guys like dpharma so much? Anything make you think this is beneficial from the cov vaccine, any agreement signed so far? Pleass share link below
22/10/2020 9:17 AM
stocktrade101 it's just hype, nothing special about Malaysia's pharma companies.
22/10/2020 9:19 AM
Godofgambler Going to fly soon!!!
22/10/2020 9:38 AM
stocktrade101 ya, but what's that got to do with dpharma and how much can dpharma make from distributing chinese vaccines (if ever) and are these halal vaccines?
22/10/2020 10:14 AM
taiwengyew Halal is more important or life Is more important? Most of thing is not halal. Our money materials also not Halal also vri
22/10/2020 10:18 AM
bigby7 Aiyoyo... Thanks to whoever that bought my early morning price ya..

My dog will enjoy a good treat..
Tips terang terang bagi tak mau..
22/10/2020 11:21 AM
bigby7 Now is the time to collect at even a lower price.. Time to park my bus low low for all of you. I am a very honest IB
22/10/2020 11:23 AM
Plantermen Vaccines are all classified halal { blood donation} but fill & process production in Malaysia is meant for export to Muslim Arab nations. China has no qualm using Malaysia as a distribution hub. Look at Geely using Proton production hub
22/10/2020 11:30 AM
TenEyeTiger The astra zenica case. The deceased was given a placebo (meningitis vaccine instead of experimental covid 19 vaccine), caught covid 19 in the process and died. Quote:Washington Post

https://www.washingtonpost.com/world/the_americas/coronavirus-oxford-astrazeneca-vaccine-trial-death/2020/10/21/3f5bedac-13c0-11eb-ad6f-36c93e6e94fb_story.html
22/10/2020 11:45 AM
kentrade888 Don't worry about the safety of Chinese vaccines.
22/10/2020 12:12 PM
henry888 Those not comfortable better stay aside/don't buy, don't ask stupid questions ?
22/10/2020 1:20 PM
James89 The Brazilian newspaper O Globo, citing unnamed sources, reported that the volunteer was in a control group that did not receive the experimental vaccine and died of covid-19. The news service G1 said the volunteer was a 28-year-old physician who treated coronavirus patients in Rio de Janeiro.
22/10/2020 1:49 PM
DrJoel88 Time to collect profits for now. Poor vaccine performance in Korea and Brazil. Deaths reported.
22/10/2020 1:58 PM
James89 Deceased AstraZeneca Trial Volunteer Didn’t Receive Vaccine

https://www.google.com.my/amp/s/www.bloomberg.com/amp/news/articles/2020-10-21/astrazeneca-dips-on-report-of-brazil-death-in-vaccine-trial
22/10/2020 5:18 PM
Plantermen Fake news
22/10/2020 7:03 PM
NoNonsenseHere Post removed. Why?
22/10/2020 7:52 PM
NoNonsenseHere Post removed. Why?
22/10/2020 7:54 PM
trade101 Why spamming supermx here??
22/10/2020 8:33 PM
Flytothesky2 https://www.chinapress.com.my/20201022/韩接种流感疫苗-死亡增至10人-皆来自国产疫苗/
23/10/2020 2:36 AM
kukubird88 https://www.cnbc.com/2020/10/22/fda-approves-gileads-remdesivir-as-coronavirus-treatment.html?__source=facebook%7Cmain&fbclid=IwAR12fE5geJyukOozuq5K6guxfw4E8i5OpiG2orlXhffYV6hwYYFaZknCK18
23/10/2020 7:39 AM
stocktrade101 remdesivir is an expensive drug, tedious to apply too. One has to be hospitalized to get treatment.
23/10/2020 8:51 AM
JDinvestor No need to SPAM glove counter information here. Irrelevant.
Admin Please delete them ~
23/10/2020 10:43 AM
foongkitmun Stil some uncertain news about vaccines....this counter might be flat today....
23/10/2020 11:39 AM
henry888 'Muhyiddin chairs a special cabinet meeting'. 3rd clinical covid trials are ongoing, nothing special. Most probably market is cautious about the direction of political.
23/10/2020 1:47 PM
Keyman188 Put more concern on Malaysia uncertainty political issue 1st...

We don't know which party will control the "Administration"...

Don't forget last month during Anwar announcement, what happened for pharmaceutical firm...

https://klse.i3investor.com/servlets/forum/906893457.jsp?fp=2


https://www.sinchew.com.my/content/content_2364143.html
23/10/2020 3:01 PM
FFF888 No one cares, is a GLC not BNLC.
23/10/2020 3:10 PM
henry888 Snap election - no lah...covid....
23/10/2020 4:02 PM
henry888 That is what Z of Umno wanted, the ultimate motive, Ai will never be PM.
23/10/2020 4:03 PM
henry888 Dpharma still ok, KJ is Umno..
23/10/2020 4:06 PM
foongkitmun Hahaha....politic de Dpahrma ka? So wanna sell or not? Down trend ka? No hope?
23/10/2020 4:07 PM
Shin888 什么情况.....
23/10/2020 5:43 PM
pineapple123 The worrying issue about the vaccine which is it will put mankind to prompt HIV infection. This is alarming!

KKM TS Norhisham have come out to warn about the vaccine testing progress yesterday.

It will not do good for Dpharma at this present time.
23/10/2020 7:16 PM
Cklew1832 Habis la ini macam
23/10/2020 7:26 PM
ramunia Don't worry too much.. Norhisham only got the news from overseas. Malaysia doesn't have lab to study or do research, most of the news are from overseas.. China vaccines confirmed can stop the covid 19
.
23/10/2020 7:33 PM
henry888 Chart looks not so nice now for short term because of political issue.
23/10/2020 7:49 PM
pineapple123 Wait and see, since 4.20 can't break it.

Will sideline for a while. I regret didn't see at 4.20 :(((
23/10/2020 7:53 PM
foongkitmun Mon fly to moon ka? Already lock liao ma....so, need to worry ka? Meaning can zzzzz this weekend lo....
23/10/2020 8:03 PM
ramunia Don't worry, my cost is rm 3.3xxx..
23/10/2020 9:09 PM
SHAH NURSYAHMIAIMAN NOOR JALAINI https://www.google.com/amp/s/www.fool.com/amp/investing/2020/10/23/can-a-coronavirus-antibody-knock-out-moderna/
23/10/2020 11:27 PM
Chong1116 https://www.chinapress.com.my/20201020/%e2%97%a4%e5%85%a8%e7%90%83%e5%a4%a7%e6%b5%81%e8%a1%8c%e2%97%a24%e6%ac%be%e7%96%ab%e8%8b%97%e8%be%be3%e6%9c%9f%e4%b8%b4%e5%ba%8a%e9%98%b6%e6%ae%b5-%e4%b8%ad%e5%9b%bd%ef%bc%9a6%e4%b8%87%e4%ba%ba/
24/10/2020 12:00 AM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

214  861  482  609 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KGROUP-OR 0.005-0.005 
 MLAB 0.02-0.005 
 AT 0.080.00 
 LAMBO 0.030.00 
 IRIS 0.265-0.04 
 LUSTER 0.175-0.015 
 DGSB 0.20+0.015 
 DAYA 0.015+0.005 
 MAHSING 1.04-0.10 
 DSONIC-WA 0.23-0.03 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
PARTNERS & BROKERS